Overview

Multiplex Detection Immunoassays Market is poised to value USD 3158.46 million by 2028 end at a CAGR of 7.5% during the forecast period 2022 to 2028.

The wide range of applications of superior detection immunoassays over conventional detection assays based on linear maintenance for many orders has been the primary factor responsible for the multiplex detection immunoassays market growth. Furthermore, the rising prevalence of chronic disorders like Alzheimer’s and cancer along with the creation of simultaneous, time-saving and cost-effective measurement of different analytes in one sample. Multiplex detection assays are suited for diagnosing autoimmune and heterogeneous diseases. In addition, these assays are utilised for identifying and measuring analytes like inflammatory proteins, kinase, growth factors and cytokine in animals. Such factors shall bolster the proliferation of the market.

Multiplex Detection Immunoassays Market Segmentation:
By Assay Type
•   Planar Assays
•   Bead-Based Assays
By Technique
•   Nuclei Acid Based Technique
•   Protein Based Technique
•   Biosensor Based Technique
By Application
•   Disease Testing
•   Food Contamination Testing
•   Research and Development
•   Veterinary Disease Testing
By End User
•   Pharmaceutical Companies
•   Clinical Research Organizations
•   Food & Beverages Companies
•   Academic Research Institutes
•   Diagnostic Centers
•   Biotechnology Centers
By Region
•   North America
•   Europe
•   Asia Pacific
•   Latin America
•   Middle East & Africa

The market is categorised into assay type, technique, application, end user and region. The assay type segment is fragmented into planar assay and bead-based assay. The planar assay segment is sub-segmented into blends protein arrays and antibody arrays while the bead-based assay segment is divided into magnetic bead-based assay and non-magnetic bead-based assay. The technique segment is diversified into nuclei acid-based technique, protein-based technique and biosensor-based technique. The application segment is bifurcated into disease testing, food contamination testing, research and development and veterinary disease testing. The end user segment is segmented into pharmaceutical companies, clinical research organizations, food & beverage companies, academic research institutes, diagnostic centres and biotech centres.

Regional Analysis:
The North America region is predicted to hold the largest multiplex detection immunoassays market share owing to advancements in immunoassay technology, increased disposable income of general population and a strong presence of major market players in the region. Furthermore, rise in the number of diagnostic centres shall boost the market growth substantially.

Competitive Landscape:
Some of the prominent market players are F. Hoffmann-La Roche AG, QIAGEN N.V, EMD Millipore, Microsynh AG., Bio-Rad, Thermo Fisher Scientific Inc., Luminex Corporation, BD Biosciences.

FutureWise Key Takeaways:
•   Growth prospects
•   SWOT analysis
•   Key market trends
•   Key data-points affecting market growth

Objectives of the Study:
•   To provide with an exhaustive analysis on the global multiplex detection immunoassays market by assay type, by technique, by application, by end user and by region
•   To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•   To evaluate and forecast micro-markets and the overall market
•   To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
•   To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers, and expansions

Flexible Delivery Model:
•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com